Asthma Obesity Phenotypes in Adults and Children

This course is part of the 2017 Virtual Annual Meeting. Want more virtual meeting recordings? Save by ordering the full set!

Session 2307 from the 2017 AAAAI Annual Meeting describes asthma endotypes in both children and adults, which recognize obesity as a major risk factor. Metabolic disease associated with obesity is also recognized as a cause of systemic and airway inflammation that may be relatively steroid resistant. Allergist-immunologists seeing these patients need to understand pathophysiology and best practice in management.

AMA PRA Category 1 Credits™: 1.25
CE: 1.25

Target Audience

Physicians
Allergists/Immunologists
Nurses
Nurse Practitioners
Allied Health Professionals

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the association of obesity and metabolic disease both in child/adolescent and adult asthma
  • Describe most effective therapies for patients with asthma and obesity
  • Discuss the role of bariatric surgery and asthma management.
Summary
Available credit: 
  • 1.25 CE
    CE credit.
  • 1.25 CME
    CME credit.
Course opens: 
05/31/2017
Course expires: 
06/14/2019
Cost:
$25.00
Part of: 
Asthma - 2017 Virtual Annual Meeting Recordings
Rating: 
0

Faculty
Dr. Anne Dixon, MD,
University of Vermont College of Medicine, Burlington, VT
Relevant relationships: None

 

Dr. Sherry Farzan, MD,
Department of Pediatrics, Division of Allergy & Immunology, Hofstra-North Shore-LIJ School of Medicine, Great Neck, NY
Relevant relationships: None

 

Stephanie Shore, PhD
Harvard School of Medicine, Boston, MA
Relevant relationships: None

Reviewers
Maria Crain, RN MA CPNP
Children’s Medical Center Dallas, Dallas, TX
Relevant relationships: None

Karen Gregory, DNP APRN-BC RRT AE-C
Oklahoma Allergy and Asthma Clinic, Edmond, OK
Relevant relationships: Merck, MEDA and Novartis: speakers bureau

Bruce Lanser, MD
National Jewish Health, Denver, CO
Relevant relationships: None

 

Disclosure link: 
2017 Annual Meeting Planning, Review and Faculty Disclosures

Accreditation Statement
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CE Designation Statement
The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 1.25 Contact Hours.

Medium and Method of Physician Participation for an Enduring Activity
Follow these steps to complete the activity:

  1. Register for the activity.
  2. Review the CME and Disclosure information.
  3. Complete all required components.
  4. Complete the post-test. You must achieve a score of 70% or higher on post-tests to claim credit.
  5. Complete the activity evaluation.
  6. Claim your credits. Enter only the number of credits earned based on your participation in the activity.
  7. Print or save your certificate.

AAAAI Privacy Policy
To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.

Release date
Original release date: June 1, 2017.  Valid for credit through May 31, 2019.

Questions
Activity-related questions should be directed to cme@aaaai.org

Available Credit

  • 1.25 CE
    CE credit.
  • 1.25 CME
    CME credit.

Price

Cost:
$25.00
Please login or register to take this course.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.

Internet Explorer is no longer supported.